Molecular Quality Control Market Analysis and Forecast to 2028 By Recent Trends, Developments in Manufacturing Technology and Regional Growth Overview
Molecular Quality Control Market Drivers
Expansion of business by key players is expected to boost the molecular
quality control market growth. For instance, in July 2016, Bio-Rad
Laboratories, Inc. announced its expansion into the molecular diagnostic
testing market with the launch of its new quality control system Amplichek
Quality Control. This quality control is used for molecular diagnostic testing
of infectious diseases.
Furthermore, in April 2019, Bruker announced the expansion for
its MALDI Biotyper, IR Biotyper and Fluorocycler XT product
lines. These products will be used for microbial identification, infection
control, and molecular diagnostics of infectious diseases.
Moreover, increasing partnership activities are expected to drive the
molecular quality control market growth. For instance, in February 2018, Randox
Laboratories announced its strategic partnership with Qnostics to enhance the
market potential of its Qnostics products.
Molecular Quality Control Market Restraints
Inaccurate genetic tests are expected to hinder growth of the molecular
quality control market. For instance, in August 2017, Invitae Corporation
identified a quality control issue with a hereditary cancer test, which
provided false, negative results. This hereditary cancer test is carried out on
those patient who have a rare genetic variant in the MSH2 gene which is
associated with the Lynch syndrome.
Molecular Quality Control Market Regional Analysis
On the basis of region, the global molecular
quality control market is segmented into North America, Latin America, Europe,
Asia Pacific, Middle East, and Africa.
North America is expected to hold a dominant position in the global
molecular quality control market, owing to increasing launches of new control
panels by key players. For instance, in December 2018, Microbiologics, Inc.
launched two new panels, Group A Streptococcus (GAS) and respiratory molecular
assays, for quality control processes. These two panels include convenient
features such as multiplexed pellets, swabs that mimic patient sample
processing, and room temperature storage.
Furthermore, Asia Pacific is also projected to witness significant
growth in the global molecular quality control market, owing to increasing
partnership activities by key players. In June 2016, Thermo Fisher Scientific
Inc., announced its partnership with West China Hospital of Sichuan University
to enhance quality of pathological research and diagnosis and to accelerate
development of precise pathological diagnosis.
Key players operating in the, global molecular quality control market
include Seracare Life Sciences, Inc., Zeptometrix, Thermo Fisher Scientific,
Abbott Laboratories, Maine Molecular Quality Controls, Inc., Quidel, Qnostics,
Bio-Rad Laboratories, Roche Diagnostics, Microbiologics, Inc., and
Theranostica.
Comments
Post a Comment